Combination therapy with angiogenesis inhibitors

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 31/282 (2006.01) A61K 31/337 (2006.01) A61K 38/19 (2006.01) A61K 45/06 (2006.01) A61P 35/00 (2006.01)

Patent

CA 2675451

Disclosed herein are methods of treating tumors using a combination therapy, wherein a VEGF antagonist and a protein kinase inhibitor capable of inhibiting at least the PDGF receptor tyronise kinase, are administered for a time and in amount sufficient to treat or prevent a tumor in a subject.

Cette invention se rapporte à des procédés de traitement des tumeurs utilisant une polychimiothérapie avec inhibiteurs de l'angiogenèse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination therapy with angiogenesis inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy with angiogenesis inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy with angiogenesis inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1483972

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.